Significant advances in treatment for chronic spontaneous urticaria (CSU), hereditary angioedema (HAE), and anaphylaxis were presented at the American Academy of Allergy, Asthma and Immunology ...

Sebetralstat is an investigational, novel oral plasma kallikrein inhibitor for the treatment of hereditary angioedema (HAE). We have filed multiple regulatory applications seeking approval of ...